Adam I. Kaplin

Psychiatry
600 N Wolfe St
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder.

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder.

Journal: Journal of affective disorders
Published: July 18, 2023

A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult Subjects.

A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult Subjects.

Journal: Drug research
Published: November 11, 2022

Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer.

Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer.

Journal: Psychopharmacology bulletin
Published: August 23, 2021

Effects of somatic treatments on suicidal ideation and completed suicides.

Effects of somatic treatments on suicidal ideation and completed suicides.

Journal: Brain and behavior
Published: May 07, 2021

Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care.

Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care.

Journal: The Lancet. Respiratory medicine
Published: March 08, 2021

Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit.

Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit.

Journal: The American journal on addictions
Published: November 27, 2020

The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors.

The Johns Hopkins Post-Acute COVID-19 Team (PACT): A Multidisciplinary, Collaborative, Ambulatory Framework Supporting COVID-19 Survivors.

Journal: The American journal of medicine
Published: November 23, 2020

Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.

Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 08, 2020

Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission.

Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission.

Journal: PloS one
Published: June 10, 2020

Perspectives on illness-related stigma and electronically sharing psychiatric health information by people with multiple sclerosis.

Perspectives on illness-related stigma and electronically sharing psychiatric health information by people with multiple sclerosis.

Journal: Journal of affective disorders
Published: June 03, 2020

An Automated Mobile Mood Tracking Technology (Mood 24/7): Validation Study.

An Automated Mobile Mood Tracking Technology (Mood 24/7): Validation Study.

Journal: JMIR mental health
Published: September 20, 2019

Explaining Naltrexone's Interference With Ketamine's Antidepressant Effect.

Explaining Naltrexone's Interference With Ketamine's Antidepressant Effect.

Journal: The American journal of psychiatry
Published: May 02, 2019
Showing 1-12 of 26

Last Updated: 09/26/2026